Therapy News and Research

RSS

Older breast cancer survivors show greater epigenetic aging than same-aged people without cancer

In a new multi-center study, researchers from the Medical College of Wisconsin (MCW) joined with leading cancer centers from across the nation to examine whether cancer and its treatments accelerate aging.

14 Jun 2023

Phenotyping identifies long COVID subtypes

Researchers discuss the phenotypes associated with long COVID inflammation.

14 Jun 2023

Study finds altered gut bacteria in people with early signs of Alzheimer's disease

People in the earliest stage of Alzheimer's disease - after brain changes have begun but before cognitive symptoms become apparent - harbor an assortment of bacteria in their intestines that differs from the gut bacteria of healthy people, according to a study by researchers at Washington University School of Medicine in St. Louis.

14 Jun 2023

Antibiotic targeting Fusobacterium reduces the formation of lesions associated with endometriosis

A research group from the Graduate School of Medicine and iGCORE at Nagoya University in Japan, has discovered that using an antibiotic to target Fusobacterium reduced the formation of lesions associated with endometriosis, a gynecological disorder characterized by endometrial tissue usually found inside the uterus being found outside it.

14 Jun 2023

New research could one day make common allergies a thing of the past

For years, research and therapies for allergic asthma have been focused largely on targeting the inflammatory cytokines in the body that react to allergens and cause overproduction of mucus, wheezing and difficulty breathing.

14 Jun 2023

Inflammation regulating gene also plays a key role in maintaining normal blood-sugar levels, study shows

A study led by researchers at the Garvan Institute of Medical Research shows for the first time how a gene called RELA, known to regulate inflammation, also plays an essential role in maintaining normal blood-sugar levels.

14 Jun 2023

OICR funding to help six Ontario-based research teams improve the lives of cancer patients

Funding announced today by the Ontario Institute for Cancer Research (OICR) will help six Ontario-based research teams pursue their ultimate goal of improving the lives of people with cancer.

14 Jun 2023

Using ultrasound for an effective sonodynamic treatment of orthotopic pancreatic cancer

Ultrasound is a promising technique for treating cancer. Unlike laser light, used in photodynamic cancer therapy, ultrasound waves can reach deep into tissue - up to 12 cm - to treat deep tumors without damaging healthy cells.

14 Jun 2023

Analysis of remission and relapse rate of type 2 diabetes mellitus in Japan

The phenomenon of improvement of glucose to levels in a normal range and cessation of the need for medication can occur in some patients diagnosed with type 2 diabetes who are provided with lifestyle therapy, temporary pharmacotherapy, bariatric surgery, or combinations of these treatments.

14 Jun 2023

Four pancreatic injury safety biomarkers identified and evaluated by PSTC

Critical Path Institute (C-Path) today announced that the Biomarker Qualification Program (BQP) at the Center for Drug Evaluation and Research (CDER) in the U.S. Food and Drug Administration (FDA) issued a Biomarker Letter of Support (LOS) for four pancreatic injury safety biomarkers identified and evaluated by C-Path's Predictive Safety Testing Consortium's (PSTC) Pancreatic Injury Working Group (PIWG).

14 Jun 2023

Immune resilience promotes longevity and resistance to infections

Researchers from The University of Texas Health Science Center at San Antonio, working with collaborators in five countries, today revealed that the capacity to resist or recover from infections and other sources of inflammatory stress - called "immune resilience" - differs widely among individuals.

13 Jun 2023

Berlin scientists further improve nasal vaccine against coronavirus

After having successfully tested a mucosal vaccine against coronavirus in animals just months ago, Berlin scientists have now further developed their live SARS-CoV-2 vaccine.

13 Jun 2023

International researchers put forward landmark proposal to diagnose, treat heart disease with neuromodulation technologies

Professor Kalyanam Shivkumar of David Geffen School of Medicine at UCLA in collaboration with Professor David Paterson, of Oxford University has been awarded a prestigious Leducq International Network of Excellence Program Award of $8 million to set up a major new transatlantic network linking world leading researchers from the United States and Europe to develop bioelectronics and therapies that target the nervous system to treat heart diseases.

13 Jun 2023

Common weight-loss surgery for obese adolescents and young adults reduces bone strength

A common weight-loss surgery for obese adolescents and young adults is found to have harmful effects on bones, according to a study published in Radiology, a journal of the Radiological Society of North America.

13 Jun 2023

Beyond exhaustion: study identifies fatigue as key factor limiting functionality in long COVID patients

Researchers assess self-documented long COVID symptoms among care-seeking individuals.

13 Jun 2023

Charles River Laboratories Launches Off-the-Shelf Lentiviral Vector Packaging Plasmids

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf lentiviral vector (LVV) packaging plasmids, providing a streamlined solution to the challenges associated with plasmid sourcing in cell and gene therapies.

From Charles Rivers Laboratories Cell and Gene Therapy 13 Jun 2023

Repeat intraocular corticosteroid injections improve vision in people with persistent or recurrent uveitic macular edema

Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a clinical trial funded by the National Eye Institute.

13 Jun 2023

Study provides a new and promising strategy for future cancer immunotherapies

CD8+ T cells, a vital component of the immune system that provides immunity against cancer, have been the focal point of anti-cancer therapies.

13 Jun 2023

Breaking barriers: hydrogel reservoir unleashes the potential of HSV-1 virotherapy in cancer

Researchers evaluated the therapeutic efficacy of Navoximod.

13 Jun 2023

Study reveals alarming pediatric antibiotic prescribing practices in Madagascar, Senegal, and Cambodia

In a recent article published in the journal PLOS Medicine, researchers performed a prospective, longitudinal study to estimate the proportion of outpatient consultations resulting in inappropriate antibiotic prescriptions in young children in three low- and middle-income countries (LMICs), Madagascar, Senegal, and Cambodia.

13 Jun 2023

Therapy News and Research

Older breast cancer survivors show greater epigenetic aging than same-aged people without cancer

Phenotyping identifies long COVID subtypes

Study finds altered gut bacteria in people with early signs of Alzheimer's disease

Antibiotic targeting Fusobacterium reduces the formation of lesions associated with endometriosis

New research could one day make common allergies a thing of the past

Inflammation regulating gene also plays a key role in maintaining normal blood-sugar levels, study shows

OICR funding to help six Ontario-based research teams improve the lives of cancer patients

Using ultrasound for an effective sonodynamic treatment of orthotopic pancreatic cancer

Analysis of remission and relapse rate of type 2 diabetes mellitus in Japan

Four pancreatic injury safety biomarkers identified and evaluated by PSTC

Immune resilience promotes longevity and resistance to infections

Berlin scientists further improve nasal vaccine against coronavirus

International researchers put forward landmark proposal to diagnose, treat heart disease with neuromodulation technologies

Common weight-loss surgery for obese adolescents and young adults reduces bone strength

Beyond exhaustion: study identifies fatigue as key factor limiting functionality in long COVID patients

Charles River Laboratories Launches Off-the-Shelf Lentiviral Vector Packaging Plasmids

Repeat intraocular corticosteroid injections improve vision in people with persistent or recurrent uveitic macular edema

Study provides a new and promising strategy for future cancer immunotherapies

Breaking barriers: hydrogel reservoir unleashes the potential of HSV-1 virotherapy in cancer

Study reveals alarming pediatric antibiotic prescribing practices in Madagascar, Senegal, and Cambodia

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News